Jaume Pons

This profile gathers the share dealings of Jaume Pons in ALX Oncology Holdings Inc, where the filings describe the role as chief executive. The record holds 60 filings, for trades running from 21 July 2020 to 19 February 2025.

Every open-market trade on record is a sale: 47 sales worth €9.3M. Besides market trades, the filings include 3 share grants and 9 option exercises. In 2025 alone, the filings show no purchases and 2 sales.

The newest entry dates from 21 February 2025: an open-market sale of €1,460, in ALX Oncology Holdings Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.